Targeted & Immunotherapy - Evidence Society For Immunotherapy Of Cancer(SITC) Consensus Definitions For Resistance To Combinations Of Immune Checkpoint Inhibitors With Targeted Therapies 8 months ago
Targeted & Immunotherapy - Evidence Society For Immunotherapy Of Cancer(SITC) Clinical Practice Guideline On Immune Checkpoint Inhibitor-Related Adverse Events 8 months ago
ESOPHAGUS New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma 11 months ago
Targeted & Immunotherapy - Evidence Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer : Practical Considerations and Recommendations 11 months ago
Targeted & Immunotherapy - Evidence Progression-Free Survival And Overall Survival Of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis 11 months ago
Targeted & Immunotherapy - Evidence CSCO Breast Cancer Guideline: Updates For Hormone Receptor-positive BC in 2020 11 months ago
Targeted & Immunotherapy - Evidence Atezolizumab Plus Bevacizumab In Advanced Unresectable Or Metastatic HCC 11 months ago
Targeted & Immunotherapy - Evidence Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update 11 months ago